Clinical trial
HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving…
NCT00001103 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001103 |
|---|---|
| Title | HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs |
| Official title | Cerebrospinal Fluid Human Immunodeficiency Virus-1 (HIV-1) and Cognitive Function in Individuals Receiving Potent Antiretroviral Therapy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Neurologic AIDS Research Consortium (NARC) |
| Status | Completed |
| Study type | Observational |
| Conditions | Cognitive Disorders, HIV Infections |
| Enrollment | 100 |
| First posted | Aug 31, 2001 |
| Last update posted | Jul 29, 2008 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: